Whether you or someone in your life has cancer, you are aware of how important ongoing cancer research is. One way to help support cancer research is to participate in research such as the integrated Cancer Repository for Cancer Research (iCaRe2).
The goals of the research registry are to develop studies that help researchers understand why people get cancer, how cancer cells work and what medications or other preventative treatments can be used. Researchers also are working to help develop tests to detect cancer earlier and start treatment sooner.
The iCaRe2 is a multi-institutional research registry and tissue bank, created and maintained by the Fred & Pamela Buffett Cancer Center to collect information and biological samples that will help researchers study possible risk factors for cancer. Future research includes the prevention, diagnosis, treatment and long-term follow-up of cancer.
The iCaRe2 registry and tissue bank aims to broaden the pool of data for cancer researchers from all over the world, giving them access to a large sample collection and ultimately improving patient care and cancer research development.
Anyone over the age of 19 is eligible to participate, even if you’ve never had cancer. If you agree to participate you will be asked to complete a survey about your medical history, diet, daily habits and your family’s medical history. Your information, like all your medical records here at UNMC and Nebraska Medicine, is covered under HIPAA, which is the federal law that protects sensitive patient health information from being shared without your consent or knowledge.
For more information or to enroll, visit the iCaRe2 website or email Michelle Desler, lead coordinator.
IRB# 253-13-EP